Group One Trading
PRVL

Group One Trading’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History

Group One Trading’s Portfolio PRVL Stock Details PRVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,200
Closed -$28K – 8296
2020
Q4 		$28K Buy
1,200
+1,100
+1,100% +$13.9K ﹤0.01% 5341
2020
Q3 		$1K Buy
+100
New +$1.34K ﹤0.01% 5998

Group One Trading's PRVL Position: Q1 2021 in Review

Group One Trading sold out of Prevail Therapeutics Inc. Common Stock (PRVL) in Q1 2021, closing a stake of 1,200 shares — an estimated $28K sold.

Group One Trading first reported a position in PRVL in Q3 2020 and held it in 2 quarters. The position peaked at $28K in Q4 2020. 0 funds tracked by Wall St. Rank hold PRVL as of Q1 2021.

  • Group One Trading reported no remaining Prevail Therapeutics Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Group One Trading sold 1,200 Prevail Therapeutics Inc. Common Stock shares in Q1 2021, an estimated $28K.
  • Group One Trading first reported a position in Prevail Therapeutics Inc. Common Stock in Q3 2020 and held it in 2 quarters.
  • Group One Trading's Prevail Therapeutics Inc. Common Stock position peaked at $28K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Prevail Therapeutics Inc. Common Stock as of Q1 2021.

Based on Group One Trading's 13F filing for Q1 2021, filed 12 May 2021.